US 12,437,873 B2
Infection detection and differentiation systems and methods
Robert T. Magari, Cooper City, FL (US); Diana B. Careaga, Miami, FL (US); Fernando P. Chaves, Brooklyn, NY (US); and Liliana M. Tejidor, Coral Gables, FL (US)
Assigned to Beckman Coulter, Inc., Brea, CA (US)
Filed by Beckman Coulter, Inc., Brea, CA (US)
Filed on Jul. 11, 2024, as Appl. No. 18/770,119.
Application 18/770,119 is a continuation of application No. 17/391,599, filed on Aug. 2, 2021, granted, now 12,062,448.
Application 17/391,599 is a continuation of application No. 16/073,757, granted, now 11,114,205, issued on Sep. 7, 2021, previously published as PCT/US2017/014708, filed on Jan. 24, 2017.
Claims priority of provisional application 62/288,091, filed on Jan. 28, 2016.
Prior Publication US 2024/0371523 A1, Nov. 7, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 50/20 (2018.01); G16H 50/30 (2018.01)
CPC G16H 50/20 (2018.01) [G16H 50/30 (2018.01)] 12 Claims
OG exemplary drawing
 
1. An automated system for evaluating the infection status associated with a blood sample obtained from an individual, the system comprising:
a conduit configured to receive and direct movement of the blood sample through an aperture;
an electrode assembly configured to pass an electric current through the blood sample as it moves through the aperture and collect data concerning the electric current; and
wherein the system is configured to evaluate the infection status based on a parameter calculated using a function comprising a monocyte volume measure based on the data concerning the electric current and a cell count or neutrophil concentration of white blood cells associated with the blood sample.